DC-derived EVs (DC-EVs) contain co-stimulatory molecules, integrin avβ2, intercellular adhesion molecule 1 (ICAM1), and other components involved in cell–cell interactions [161], which allows DC-EVs to control tumor immune escape by modulating immune stimulation, thereby inhibiting tumor progression [162]. Here, ICAM1 is linked to neoplasm.